News and Announcements
Engender Technolgies A Finalist in Silicon Valley Tech Challenge
- Published May 23, 2016 2:06PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
23rd May 2016, NZ Herald By Jamie Morton
An innovative Kiwi start-up company has been named as a finalist for a prestigious tech challenge to be held in California’s Silicon Valley next month.
Engender Technologies, which is commercialising cutting-edge photonics tech developed by Associate Professor Cather Simpson of the University of Auckland, will compete in the third annual World Cup Tech Challenge before major players in the world’s tech scene.
Start-ups accepted into the challenge are considered in a “pre-global” stage, meaning they have launched their products in their respective local markets and now ready for a global launch.
It comes soon after Engender Technologies was also named among the finalists of the KiwiNet Research Commercialisation Awards.
Since Associate Professor Simpson founded the university’s Photon Factory six years ago, the facility has attracted more than $2 million in commercial contracts.
To view the full article, please click on the button below.
To register your interest, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
